全球ATP檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計 ATP 檢測市場將從 2025 年的 9.7 億美元成長到 2034 年的 20 億美元，2026 年至 2034 年的複合年成長率為 8.29%。

受製藥、生物技術和食品安全產業對快速污染檢測和細胞活力檢測需求不斷成長的推動，全球ATP檢測市場持續穩定擴張。藥物研發投入的增加以及醫療機構對衛生監測日益重視，也進一步提升了市場滲透率。由於ATP檢測能夠快速、靈敏、可靠地檢測生物殘留物，因此在全球範圍內，它已成為品管和微生物檢測領域極具價值的技術。

關鍵成長要素包括嚴格的衛生管理和感染控制監管標準，特別是在醫院和食品加工環境中。生物製藥生產和細胞研究的激增進一步增加了對基於ATP的發光檢測的需求。攜帶式發光儀和自動化檢測平台等技術進步正在提高效率，並擴大新興經濟體的應用範圍。

展望未來，亞太地區生命科學研發投入的增加和製藥業的擴張預計將為市場發展提供強勁動力。發展中地區對快速衛生監測解決方案的日益重視也將創造新的機會。 ATP檢測與數位資料管理系統和自動化技術的整合將提高工作流程效率，並促進市場的永續長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球ATP檢測市場：依產品分類

• 市場分析、洞察與預測
• 耗材和配件
• 試劑
• 微孔盤
• 其他耗材和配件
• 裝置
• 發光計
• 光強度

第5章：全球ATP檢測市場：按應用分類

• 市場分析、洞察與預測
• 污染測試
• 疾病檢測
• 藥物發現與開發

第6章：全球ATP檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 食品飲料業
• 醫院/診斷檢查室
• 學術研究機構

第7章 全球ATP檢測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Promega Corporation
  • Merck KGaA
  • PerkinElmer Inc
  • Agilent Technologies Inc
  • Abcam Plc
  • Lonza Group
  • Neogen Corporation
  • 3M
  • Danaher Corporation
  • PromoCell GmbH
  • Geno Technology Inc
  • Abnova Corporation
  • AAT Bioquest Inc
  • BioThema AB

The ATP Assays Market size is expected to reach USD 2.00 Billion in 2034 from USD 0.97 Billion (2025) growing at a CAGR of 8.29% during 2026-2034.

The Global ATP Assays Market is witnessing steady expansion driven by rising demand for rapid contamination detection and cellular viability testing across pharmaceutical, biotechnology, and food safety industries. Increasing R&D investments in drug discovery and growing focus on hygiene monitoring in healthcare facilities are strengthening market penetration. ATP assays offer quick, sensitive, and reliable detection of biological residues, making them highly valuable in quality control and microbial testing applications worldwide.

Key growth drivers include stringent regulatory standards for sanitation and infection control, particularly in hospitals and food processing environments. The surge in biologics production and cell-based research has further elevated demand for ATP-based luminescence assays. Technological advancements such as portable luminometers and automated detection platforms are enhancing efficiency and expanding adoption across emerging economies.

Looking ahead, the market is expected to benefit from rising investments in life sciences research and expanding pharmaceutical manufacturing in Asia-Pacific. Growing awareness of rapid hygiene monitoring solutions in developing regions will create additional opportunities. Integration of ATP assays with digital data management systems and automation is likely to improve workflow efficiency, positioning the market for sustainable long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Consumables & Accessories
• Reagent
• Microplates
• Other Consumables & Accessories
• Instruments
• Luminometers
• Spectrophotometers

By Application

• Contamination Testing
• Disease Testing
• Drug Discovery and Development

By End User

• Pharmaceutical & Biotechnology companies
• Food and Beverage Industry
• Hospitals and Diagnostic Laboratories
• Academic and Research Institutions

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Promega Corporation, Merck KGaA, PerkinElmer Inc, Agilent Technologies Inc, Abcam plc, Lonza Group, Neogen Corporation, 3M, Danaher Corporation, PromoCell GmbH, Geno Technology Inc, Abnova Corporation, AAT Bioquest Inc, BioThema AB
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ATP ASSAYS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Consumables & Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Microplates Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Other Consumables & Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Luminometers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Spectrophotometers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ATP ASSAYS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Contamination Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Discovery and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ATP ASSAYS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharmaceutical & Biotechnology companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Food and Beverage Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospitals and Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Academic and Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ATP ASSAYS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ATP ASSAYS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Promega Corporation
  • 9.2.3 Merck KGaA
  • 9.2.4 PerkinElmer Inc
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Abcam Plc
  • 9.2.7 Lonza Group
  • 9.2.8 Neogen Corporation
  • 9.2.9 3M
  • 9.2.10 Danaher Corporation
  • 9.2.11 PromoCell GmbH
  • 9.2.12 Geno Technology Inc
  • 9.2.13 Abnova Corporation
  • 9.2.14 AAT Bioquest Inc
  • 9.2.15 BioThema AB